About Omalizumab
            
            Class: | Monoclonal antibody (anti-IgE)  
Use: | Treatment of moderate to severe persistent asthma in patients 6 years and older, chronic idiopathic urticaria in patients 12 years and older, and nasal polyps in adults.  
Adult dose: | 150 mg to 375 mg subcutaneously every 2 to 4 weeks, depending on body weight and asthma severity.  
Pediatric dose: | 150 mg subcutaneously every 2 to 4 weeks for patients aged 6 to 11 years, based on body weight (weight-based dosing).  
Side effects: | Injection s
         
        
            
                
                
                    
                        Drug Class
                    
                    Monoclonal antibody (anti-IgE)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of moderate to severe persistent asthma in patients 6 years and older, chronic idiopathic urticaria in patients 12 years and older, and nasal polyps in adults.
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light.
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: NOVARTIS EUROPHARM LIMITED, IRELAND
                    
                    
                    Package Size
                    1 Pre-filled Syringe
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 2308.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        150 mg to 375 mg subcutaneously every 2 to 4 weeks, depending on body weight and asthma severity.
                    
                    
                        Pediatric Dose
                    
                    
                        150 mg subcutaneously every 2 to 4 weeks for patients aged 6 to 11 years, based on body weight (weight-based dosing).
                    
                 
                
                
                    
                        Side Effects
                    
                    Injection site reactions, headache, dizziness, fatigue, abdominal pain, and anaphylaxis (rare).
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to omalizumab or any component of the formulation; acute bronchospasm; and use in patients with a history of severe allergic reactions to any other monoclonal antibody.
         
        
        
            
                Important Warnings
            
            Risk of anaphylaxis; monitor patients for signs of hypersensitivity; may increase the risk of cardiovascular and cerebrovascular events; not indicated for the treatment of acute asthma symptoms.
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.